VN December 2020
Vetnuus |Desember 2020 38 Rosie Lyle of Bishopton Veterinary Group, a member of XLVets and lead author of the study, said: “It’s important for both farmers and vets to be aware of potential concerns about vaccine efficacy, given the possible impact on herd health and the potential for vaccine failure to reduce trust in vaccines and herd health recommendations.” In the study, 18 farmers placed temperature loggers in the fridge where they normally store vaccines. Between February and April, 89 per cent of loggers recorded a temperature outside the recommended 2–8°C range at least once, and 43 per cent recorded temperatures outside this range more than 50 per cent of the time. It was noted that 55 per cent of the loggers recorded a temperature over 8°C, and 39 per cent recorded a temperature below 2°C. Across all the fridges monitored, the maximum temperature recorded was 12°C, and the minimum was -11.5°C. “These findings are concerning for farmers as we know that both too high and too low temperatures can impair vaccine efficacy,” said Rosie, adding that live vaccines tend to be particularly sensitive to elevated temperatures while inactivated vaccines are more affected by freezing. In light of the findings, farmers are being encouraged to use max/min thermometers or temperature loggers to track fridge temperature and take steps to maximise the efficiency of each fridge. Simple interventions might include ensuring fridges are not subject to wide variations in external temperature and enabling adequate airflow, said XLVets. v (Source: https://mrcvs.co.uk ) Majority of farm fridges record temperatures outside recommended range for vaccines<<< 37 Bits and Bobs I Stukkies en Brokkies Treatment for canine ocular condition using turmeric Uveitis – a common condition in dogs, humans, and other species – can have many causes, often occurring secondary to infectious diseases, cancer, and autoimmune diseases; it also is found in patients with longstanding cataracts and after operations correcting cataracts. “Uveitis, is a leading cause of complications after cataract surgery in dogs. The management of postoperative ocular inflammation is a major challenge observed in both human and veterinary ophthalmology," said Dr Erin Scott, an assistant professor at the Texas A&M University College of Veterinary Medicine & Biomedical Sciences. In a recent paper published in Science Advances , Scott and her colleagues at the Texas A&M University College of Pharmacy tested the anti-inflammatory properties of curcumin, a compound found in turmeric, and discovered that when processed to a special nanoparticle formulation to boost absorption, the natural compound is safe and effective at managing uveitis without any known side effects. Oral medications currently used to treat uveitis must be adequately absorbed into the blood stream for their medicinal effects to be effective. Drug delivery to the eye presents additional challenges because of the blood-ocular barrier which tightly controls what substances can pass into the eye. Therefore, researchers must find ways to bypass such barriers to improve drug availability within the body. Scott and her colleagues' research implemented a novel formulation of curcumin that improved transport of the substance across both intestinal and ocular barriers. By adding nanoparticle molecules that interact with receptors on a ubiquitous transmembrane carrier protein, known as the transferrin receptor, curcumin is able to hitch a ride across crucial barriers, improving absorption of the substance and reducing ocular inflammation. Curcumin is especially attractive as a candidate for management of uveitis because it has no known side effects. "Current treatments include a combination of systemic and topical anti-inflammatory medications, either in the form of steroids or non-steroidal anti- inflammatory drugs (NSAIDs)," Scott said. "While both these medications are effective in the treatment of uveitis, they can cause unwanted side effects” Scott and her colleagues hope to start a clinical trial in the Texas A&M Veterinary Medical Teaching Hospital using this new medication in the near future and are optimistic that the utility of their findings may benefit populations beyond dogs. "This medication may translate to the treatment of cataracts and uveitis in humans," she said. "By studying animal patients with naturally occurring eye diseases, our findings may accelerate the development of medications to benefit both animals and humans." v (Source: www.sciencedaily.com )
Made with FlippingBook
RkJQdWJsaXNoZXIy OTc5MDU=